6 Matching Annotations
  1. Last 7 days
    1. Supplementary Data: Table 2

      Case C: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, partial testing (MYH7, CSRP3, DES, LMNA, MYBPC3, TNNT2, TNNI3)

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    2. Supplementary Data: Table 2

      Case E: proband, male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) PRDM16 Variant:

      Variant: NM_022114.3(PRDM16):c.2666C>T (p.Pro889Leu)

      ClinVar: 487607, https://www.ncbi.nlm.nih.gov/clinvar/variation/487607/

      gnomAD: 0.0001771, https://gnomad.broadinstitute.org/variant/1-3331186-C-T

    3. Supplementary Data: Table 2

      Case G: proband, Male

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, partial testing (MYH7)

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    4. Supplementary Data: Table 2

      Case O:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) BAG3 Variant:

      Variant: NM_004281.3:c.1090G>A

      CAID: CA214224881, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA214224881

      gnomAD: n/a

    5. Supplementary Data: Table 2

      Case 1:

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: WES, Cytoscan HD SNP array (performed on proband, 3 additional carriers, and parents)

      Variant 1 - maternal: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      Variant 2 - paternal: NM_000257.3:c.328G>A

      CAID: CA036654, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA036654

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23902310-C-T

      MultipleGeneVariants:

      (1) FHL1 Variant:

      Variant (maternal): NM_001159702.2:c.968C>T

      CAID: CA10525127, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA10525127

      gnomAD: 0.000005449, https://gnomad.broadinstitute.org/variant/X-135292109-C-T

      (2) SYNE1 Variant:

      Variant (maternal): NM_033071.3(SYNE1):c.18514G>A (p.Glu6172Lys)

      ClinVar: 199251, https://www.ncbi.nlm.nih.gov/clinvar/variation/199251/

      gnomAD: 0.00003536, https://gnomad.broadinstitute.org/variant/6-152589279-C-T

    6. Supplementary Data: Table 2

      Case I: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a